Literature DB >> 10910050

Human carcinoembryonic antigen functions as a general inhibitor of anoikis.

C Ordoñez1, R A Screaton, C Ilantzis, C P Stanners.   

Abstract

Human carcinoembryonic antigen (CEA), a widely used tumor marker, and CEACAM6 [formerly nonspecific cross-reacting antigen (NCA)] are up-regulated in many types of human cancers, whereas family member CEACAM1 [formerly biliary glycoprotein (BGP)] is usually down-regulated. Deregulated overexpression of CEA/CEACAM6 but not CEACAM1 can inhibit the differentiation and disrupt the polarization and tissue architecture of many different types of cells. In this report, we show that CEA and CEACAM6, but not CEACAM1, markedly inhibit the apoptosis of cells when deprived of their anchorage to the extracellular matrix, a process known as anoikis. By blocking this tissue architecture surveillance mechanism, the architectural perturbation initiated by CEA/CEACAM6 can thus be maintained.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10910050

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  85 in total

1.  Toward a functional annotation of the human genome using artificial transcription factors.

Authors:  Dong-ki Lee; Jin Woo Park; Youn-Jae Kim; Jiwon Kim; Yangsoon Lee; Jeonglim Kim; Jin-Soo Kim
Journal:  Genome Res       Date:  2003-12       Impact factor: 9.043

2.  Factors influencing response to neoadjuvant chemoradiation and outcomes in rectal cancer patients: tertiary Indian cancer hospital experience.

Authors:  Reena Engineer; Trinanjan Basu; Supriya Chopra; Supreeta Arya; Prachi Patil; Shaesta Mehta; Mukta Ramadwar; Kedar Deodhar; Shyam Kishore Shrivastava
Journal:  J Gastrointest Oncol       Date:  2015-04

Review 3.  Avoiding hepatic metastasis naturally: Lessons from the cotton top tamarin (Saguinus oedipus).

Authors:  Martin Tobi; Peter Thomas; Daniel Ezekwudo
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

4.  Defect in CEACAM family member expression in Crohn's disease IECs is regulated by the transcription factor SOX9.

Authors:  Giulia Roda; Stephanie Dahan; Laura Mezzanotte; Alessandra Caponi; Franziska Roth-Walter; David Pinn; Lloyd Mayer
Journal:  Inflamm Bowel Dis       Date:  2009-07-27       Impact factor: 5.325

5.  Abnormal Golgi pH Homeostasis in Cancer Cells Impairs Apical Targeting of Carcinoembryonic Antigen by Inhibiting Its Glycosyl-Phosphatidylinositol Anchor-Mediated Association with Lipid Rafts.

Authors:  Nina Kokkonen; Elham Khosrowabadi; Antti Hassinen; Deborah Harrus; Tuomo Glumoff; Thomas Kietzmann; Sakari Kellokumpu
Journal:  Antioxid Redox Signal       Date:  2018-02-12       Impact factor: 8.401

6.  Blocking the attachment of cancer cells in vivo with DNA aptamers displaying anti-adhesive properties against the carcinoembryonic antigen.

Authors:  Erik W Orava; Aws Abdul-Wahid; Eric H-B Huang; Amirul Islam Mallick; Jean Gariépy
Journal:  Mol Oncol       Date:  2013-04-11       Impact factor: 6.603

7.  Carcinoembryonic antigen-related cell adhesion molecule 10 expressed specifically early in pregnancy in the decidua is dispensable for normal murine development.

Authors:  Daniela Finkenzeller; Beate Fischer; Sabine Lutz; Heinrich Schrewe; Takehiko Shimizu; Wolfgang Zimmermann
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

8.  Normal carcinoembryonic antigen indicates benefit from perioperative chemotherapy to gastric carcinoma patients.

Authors:  Shi Chen; Ying-Bo Chen; Yuan-Fang Li; Xing-Yu Feng; Zhi-Wei Zhou; Xiu-Hong Yuan; Chao-Nan Qian
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

Review 9.  Sry-box (Sox) transcription factors in gastrointestinal physiology and disease.

Authors:  A D Gracz; S T Magness
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-03       Impact factor: 4.052

10.  Deregulation of the CEACAM expression pattern causes undifferentiated cell growth in human lung adenocarcinoma cells.

Authors:  Bernhard B Singer; Inka Scheffrahn; Robert Kammerer; Norbert Suttorp; Suleyman Ergun; Hortense Slevogt
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.